Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Japan Life Science Tools Market

4. Executive Summary

5. Japan Life Science Tools Market Outlook, FY2017-FY20301

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Type
  • 5.2.1. Instruments
  • 5.2.2. Consumables
  • 5.2.3. Services
• 5.3. By Technology
  • 5.3.1. Genomics
  • 5.3.2. Proteomics
  • 5.3.3. Cell Biology Technology
  • 5.3.4. Lab Supplies
  • 5.3.5. Others
• 5.4. By Product
  • 5.4.1. Cell Culture Systems & 3D Cell Culture
  • 5.4.2. Liquid Chromatography
  • 5.4.3. Mass Spectrometry
  • 5.4.4. Flow Cytometry
  • 5.4.5. Cloning & Genome Engineering
  • 5.4.6. Microscopy & Electron Microscopy
  • 5.4.7. Next Generation Sequencing
  • 5.4.8. PCR & qPCR
  • 5.4.9. Nucleic Acid Preparation
  • 5.4.10. Nucleic Acid Microarray
  • 5.4.11. Sanger Sequencing
  • 5.4.12. Transfection Devices & Gene Delivery Technologies
  • 5.4.13. Nuclear Magnetic Resonance (NMR)
  • 5.4.14. Others
• 5.5. By End-user
  • 5.5.1. Healthcare
    • 5.5.1.1. Hospitals
    • 5.5.1.2. Clinics
    • 5.5.1.3. Research Laboratories
    • 5.5.1.4. Diagnostic Laboratories
    • 5.5.1.5. Physician Office
    • 5.5.1.6. Community Centres
  • 5.5.2. Government & Academic Institutions
  • 5.5.3. Biopharmaceutical Company
  • 5.5.4. Industrial Applications
  • 5.5.5. Others
• 5.6. By Region
  • 5.6.1. North - Hokkaido and Tohoku
  • 5.6.2. South - Kansai, Chugoku, Shikoku, and Kyushu & Okinawa
  • 5.6.3. Central - Kanto and Chubu
• 5.7. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By Type
• 6.2. By Technology
• 6.3. By Product
• 6.4. By End-user
• 6.5. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis - Volume and Value
• 7.3. Supply/Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Becton, Dickinson, and Company
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Becton, Dickinson, and Company
• 13.3. Shimadzu Corporation
• 13.4. Hitachi High-Tech Corporation
• 13.5. JEOL Ltd.
• 13.6. Sysmex Corporation
• 13.7. Agilent Technologies
• 13.8. Thermo Fisher Scientific Inc.
• 13.9. F. Hoffmann-La Roche Ltd
• 13.10. Bio-Rad Laboratories Inc.
• 13.11. Merck KGaA
• 13.12. Qiagen NV
• 13.13. Abbott Laboratories Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer